C4 Therapeutics to Present at Two Key Healthcare Conferences in March
Event summary
- C4 Therapeutics management will present at the TD Cowen 46th Annual Healthcare Conference on March 3, 2026, in Boston.
- The company will also participate in a fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 10, 2026, in Miami.
- Live webcasts will be available on the company’s website, with replays accessible for 90 days post-event.
The big picture
C4 Therapeutics' participation in high-profile healthcare conferences underscores its push to engage with investors and industry stakeholders as it advances its clinical-stage oncology programs. The events provide a platform to showcase its TORPEDO® platform, which aims to address difficult-to-treat diseases through targeted protein degradation. The company's ability to articulate its strategic vision and clinical progress will be critical in shaping market perception.
What we're watching
- Investor Sentiment
- How C4 Therapeutics' presentations will impact investor confidence amid ongoing clinical-stage developments.
- Strategic Messaging
- Whether the company can effectively communicate its TORPEDO® platform advancements to attract potential partners or investors.
- Market Differentiation
- The pace at which C4 Therapeutics can distinguish itself in the competitive targeted protein degradation space.